Skip to content

SPRAY CATHETER PW-6C-1Recalls & reported problems

Olympus Medical Systems Corp. · "PW-6C-1.B SPRAY CATH 105CM LGTH 2.0MM CH" · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04953170062391), received between Oct 5, 2023 and Oct 5, 2023 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Decreased Appetite1
  • Low Oxygen Saturation1
  • Pneumonia1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 5, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    OLYMPUS MEDICAL SYSTEMS CORP. (OMSC) RECEIVED A LITERATURE TITLED "CLOSE-TO-LESION TRANSBRONCHIAL BIOPSY: A NOVEL TECHNIQUE TO IMPROVE SUITABILITY OF SPECIMENS FOR GENETIC TESTING IN PATIENTS WITH PERIPHERAL PULMONARY LESIONS". LITERATURE SUMMARY BRONCHOSCOPY WITH RADIAL-PROBE ENDOBRONCHIAL ULTRASOUND, A GUIDE SHEATH, AND ELECTROMAGNETIC NAVIGATION CAN IMPROVE THE DIAGNOSTIC YIELD OF PERIPHERAL LUNG NODULES. HOWEVER, THE SUITABILITY OF SPECIMENS FOR GENETIC ANALYSIS REMAINS UNSATISFACTORY. WE HYPOTHESIZED THAT A TRANSBRONCHIAL BIOPSY PERFORMED AFTER CLOSELY APPROACHING THE BRONCHOSCOPE TIP TO THE LESION MIGHT PROVIDE MORE SUITABLE SPECIMENS FOR GENETIC ANALYSIS. WE ENROLLED 155 PATIENTS WITH PERIPHERAL PULMONARY LESIONS WHO UNDERWENT BRONCHOSCOPY WITH A THIN OR ULTRATHIN BRONCHOSCOPE. BRONCHOSCOPY WAS PERFORMED USING VIRTUAL BRONCHOSCOPIC NAVIGATION AND RADIAL-PROBE ENDOBRONCHIAL ULTRASOUND WITH A GUIDE SHEATH. THE BRONCHOSCOPE TIP WAS PLACED CLOSER TO THE LESION DURING BRONCHOSCOPY TO COLLECT LARGER SPECIMENS WITH HIGHER MALIGNANT CELL CONTENT. THE PATIENTS WHO UNDERWENT A CLOSE-TO-LESION BIOPSY HAD HIGHER RATES OF OVERALL DIAGNOSTIC YIELD, HISTOPATHOLOGICAL DIAGNOSTIC YIELD, AND

    Patient problems: Decreased Appetite; Low Oxygen Saturation; Pneumonia

    MAUDE report 17878789 ↗

Other NASOPHARYNGOSCOPE (FLEXIBLE OR RIGID) devices

All NASOPHARYNGOSCOPE (FLEXIBLE OR RIGID) devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page